145 related articles for article (PubMed ID: 19912520)
1. Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.
Oyama MA; Levy RJ
J Vet Intern Med; 2010; 24(1):27-36. PubMed ID: 19912520
[TBL] [Abstract][Full Text] [Related]
2. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
3. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
4. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
Aupperle H; Disatian S
J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways in mitral valve degeneration.
Orton EC; Lacerda CM; MacLea HB
J Vet Cardiol; 2012 Mar; 14(1):7-17. PubMed ID: 22364692
[TBL] [Abstract][Full Text] [Related]
6. Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.
Oyama MA; Chittur SV
Am J Vet Res; 2006 Aug; 67(8):1307-18. PubMed ID: 16881841
[TBL] [Abstract][Full Text] [Related]
7. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
Disatian S; Orton EC
J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
[TBL] [Abstract][Full Text] [Related]
8. The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
Sakarin S; Surachetpong SD; Rungsipipat A
Front Vet Sci; 2020; 7():612130. PubMed ID: 33426031
[No Abstract] [Full Text] [Related]
9. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
10. Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.
Driesbaugh KH; Branchetti E; Grau JB; Keeney SJ; Glass K; Oyama MA; Rioux N; Ayoub S; Sacks MS; Quackenbush J; Levy RJ; Ferrari G
J Mol Cell Cardiol; 2018 Feb; 115():94-103. PubMed ID: 29291394
[TBL] [Abstract][Full Text] [Related]
11. Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves.
Lacerda CM; Maclea HB; Kisiday JD; Orton EC
J Vet Cardiol; 2012 Mar; 14(1):223-30. PubMed ID: 22364693
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England.
Mattin MJ; Boswood A; Church DB; López-Alvarez J; McGreevy PD; O'Neill DG; Thomson PC; Brodbelt DC
J Vet Intern Med; 2015; 29(3):847-54. PubMed ID: 25857638
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment.
Oyama MA
J Small Anim Pract; 2009 Sep; 50 Suppl 1():3-11. PubMed ID: 19765215
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
15. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
[TBL] [Abstract][Full Text] [Related]
16. New insights into degenerative mitral valve disease in dogs.
Häggström J; Duelund Pedersen H; Kvart C
Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1209-26, vii-viii. PubMed ID: 15325478
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease.
Lee CM; Han JI; Kang MH; Kim SG; Park HM
J Vet Sci; 2018 Jan; 19(1):129-135. PubMed ID: 28693307
[TBL] [Abstract][Full Text] [Related]
18. Pathology of myxomatous mitral valve disease in the dog.
Fox PR
J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
[TBL] [Abstract][Full Text] [Related]
19. Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.
Lu CC; Liu MM; Culshaw G; Clinton M; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):23-31. PubMed ID: 25841900
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
Disatian S; Lacerda C; Orton EC
J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
